What is Kenvue Inc.'s (KVUE) StockRank?

MoatMap's StockRank for Kenvue Inc. (KVUE) is 76/100, with a Buy signal. This is a composite score combining Quality (56), Value (36), and Momentum (78) factor ranks across MoatMap's 20,000+ stock universe.

Does Kenvue Inc. have an economic moat?

Kenvue Inc. (KVUE) has a Quality factor score of 56/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Kenvue Inc. a buy, hold, or sell?

MoatMap's current signal for Kenvue Inc. (KVUE) is Buy, based on a StockRank of 76/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Kenvue Inc. in?

Kenvue Inc. (KVUE) operates in the Consumer Defensive sector, specifically the Household & Personal Products industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

KVUE

BUY

Kenvue Inc. · Consumer Defensive · United States · $37.0B · Avg Vol: $409M/d

StockRank

Get insider-trade alerts

P/E (TTM)

22.6x

ROE

15.7%

D/E

0.8x

Dividend %

4.4%

COMPANY DESCRIPTION

Kenvue Inc. is a pure-play consumer health company, spun off from Johnson & Johnson, that boasts an unparalleled portfolio of iconic, market-leading brands across Self Care, Skin Health & Beauty, and Essential Health segments, including Tylenol, Band-Aid, and Neutrogena. The company's formidable competitive moat stems from deep consumer trust, global brand recognition, extensive R&D capabilities, and a vast distribution network inherited from its former parent. This collection of household names ensures resilient demand in the defensive consumer health sector.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR	TTM	2026E	2027E	Fwd CAGR
Revenue	14.9B	15.4B	15.5B	15.1B	0.4%	15.3B	15.6B	16.0B	2.9%
EPS	1.09	0.90	0.54	0.77	-11.0%	0.84	0.84	0.88	7.1%
Shares	1.9B	1.9B	1.9B	1.9B	+1.4%	1.9B	—	—	—
Debt	116.0M	8.4B	8.7B	8.7B	321.3%	8.8B	—	—	—
Equity	20.0B	11.2B	9.7B	10.8B	-18.6%	—	—	—	—
Op CF	2.5B	3.2B	1.8B	2.2B	-4.5%	2.3B	—	—	—
Inv CF	-390.0M	-488.0M	-425.0M	-436.0M	—	—	—	—	—
Fin CF	-1.6B	-2.5B	-1.6B	-1.8B	—	—	—	—	—

Loading 1Y...

PRICE (1Y)+7.4%

SMA 50SMA 200

$19.79

RSI (14)

61.2

52W High

$21.44

From 52W High

0.9%

SCORE BREAKDOWN

Quality

ROIC

11.5%57.3

ROE

15.7%73.1

GP/Assets

33.1%60.4

Op. Margin

21.6%88.2

FCF/Assets

6.9%68.3

Piotroski

648.0

Int. Cover

5.6x33.8

D/E Ratio

0.83x27.8

Current Ratio

0.98x22.4

Value

P/E (TTM)

22.6x31.4

EV/EBITDA

12.8x30.2

P/FCF

19.9x45.8

P/B

3.4x20.2

P/S

2.4x20.6

Div Yield

4.4%74.0

Momentum

52W High %

92%75.2

RS 6M

10%81.6

SMA 50/200

1.07x81.2

EPS Rev 4W

+0.2%90.7

EPS Rev 12W

+2.8%86.6

EPS Improve

+48%59.3

Q Growth

47%77.3

FUNDAMENTALS

Market Cap

$37.0B

P/E (Forward)

15.3x

Gross Margin

58.6%

SECTOR PEERS

Closest peers in Consumer Defensive, ranked by industry match, size, and score similarity. Cross-listings of KVUE are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
KVUE	Kenvue Inc.(you)	$37.0B	76	BUY
KMB.MX	Kimberly-Clark Corporation	$35.4B	80	STRONG BUY
CPA.DE	Colgate-Palmolive Company	$73.3B	74	BUY
CHD	Church & Dwight Co., Inc.	$23.1B	60	HOLD
PG.MX	The Procter & Gamble Company	$346.0B	71	BUY
IPAR	Interparfums, Inc.	$3.9B	85	STRONG BUY
EL	The Estée Lauder Companies Inc.	$29.0B	23	SELL
CLX	The Clorox Company	$11.6B	38	HOLD
SPB	Spectrum Brands Holdings, Inc.	$2.0B	84	STRONG BUY
EPC	Edgewell Personal Care Company	$1.3B	76	BUY

Peer medians: ROE 12.3% · P/E 21.3x · Gross margin 35.0%